VistaGen Therapeutics, Inc. - VTGN

SEC FilingsOur VTGN Tweets

About Gravity Analytica

Recent News

  • 09.26.2025 - Elemer Piros
  • 09.26.2025 - Elemer Piros
  • 09.18.2025 - TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry Conference
  • 09.18.2025 - TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry Conference
  • 09.09.2025 - Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
  • 09.09.2025 - Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
  • 08.07.2025 - Vistagen Therapeutics Fiscal Year 2026 First Quarter Corporate Update Conference Call
  • 08.07.2025 - Vistagen Therapeutics Fiscal Year 2026 First Quarter Corporate Update Conference Call
  • 08.07.2025 - Vistagen Reports Fiscal Year 2026 First Quarter Financial Results and Corporate Update
  • 08.07.2025 - Vistagen Reports Fiscal Year 2026 First Quarter Financial Results and Corporate Update

Recent Filings

  • 09.15.2025 - 8-K Current report
  • 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.11.2025 - 4 Statement of changes in beneficial ownership of securities
  • 09.08.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
  • 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.07.2025 - EX-99.1 EX-99.1